ARCHIVES

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

This article is from The Cancer Letter archive.

Vol. 29 No. 15 | April 11, 2003

Download PDF Visit The Full Archive

Related Articles

GAO Finds Little Wrong With Drug Testing Program, But Offers Some Suggestions Anyways

July 1, 1983

Varmus Appoints Group On Intellectual Property

May 8, 1998

DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards

November 5, 1982

NIH Inquiry Finds No Impropriety In Treatment of Teddy DeVita

April 9, 1976

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

February 9, 1990

NCI Advisory Group, Other Cancer Meetings For September, October

August 27, 1976